NORDIMET® PEN

Indications

Nordimet is indicated for the treatment of:

 

- active rheumatoid arthritis in adult patients,

 

- polyarthritic forms of severe, active juvenile idiopathic   arthritis (JIA), when the response to nonsteroidal

anti-inflammatory drugs (NSAIDs) has been inadequate,

 

- severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet A (PUVA), and retinoids,

 

- severe psoriatic arthritis in adult patients.

 

- Induction of remission in moderate

steroid-dependent Crohn's disease in

adult patients, in combination with

corticosteroids and for maintenance of

remission, as monotherapy, in patients

who have responded to methotrexate.